PROFOUND MEDICAL CORP. Comprehensive Income
PROFOUND MEDICAL CORP. (PROF) reported Comprehensive Income of -$10.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- PROFOUND MEDICAL CORP. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$10.49M.
- PROFOUND MEDICAL CORP. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$8.06M.
- PROFOUND MEDICAL CORP. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$7.90M.
- PROFOUND MEDICAL CORP. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$8.79M.
- PROFOUND MEDICAL CORP. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$40.29M.
- PROFOUND MEDICAL CORP. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$30.64M.
- PROFOUND MEDICAL CORP. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$27.68M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.49M 10-Q · filed 2026-08-06 | -$18.55M 10-Q · filed 2026-08-06 | -$26.45M derived: sum of 3 quarters · filed 2026-08-06 | -$35.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$8.06M 10-Q · filed 2026-05-07 | -$15.96M derived: sum of 2 quarters · filed 2026-05-07 | -$24.74M derived: sum of 3 quarters · filed 2026-05-07 | -$37.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$16.68M derived: sum of 2 quarters · filed 2026-03-05 | -$29.67M derived: sum of 3 quarters · filed 2026-08-06 | -$40.29M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$8.79M 10-Q · filed 2025-11-13 | -$21.77M derived: sum of 2 quarters · filed 2026-08-06 | -$32.39M 10-Q · filed 2025-11-13 | -$39.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$12.98M 10-Q · filed 2026-08-06 | -$23.60M 10-Q · filed 2026-08-06 | -$30.52M derived: sum of 3 quarters · filed 2026-08-06 | -$39.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$10.62M 10-Q · filed 2026-05-07 | -$17.54M derived: sum of 2 quarters · filed 2026-05-07 | -$26.32M derived: sum of 3 quarters · filed 2026-05-07 | -$33.71M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$15.70M derived: sum of 2 quarters · filed 2026-03-05 | -$23.09M derived: sum of 3 quarters · filed 2026-03-05 | -$30.64M 10-K · filed 2026-03-05 |
| 2024-09-30 | -$8.78M 10-Q · filed 2025-11-13 | -$16.17M derived: sum of 2 quarters · filed 2025-11-13 | -$23.72M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$7.39M 10-Q · filed 2025-08-14 | -$14.94M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$7.55M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$27.68M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |